Position in ABBV
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$137,484,128
-$5,663,029 QoQ
Shares Held
632,140
+0.9% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. ABBV ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,484,128 | 632,140 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $143,147,157 | 626,492 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $134,569,195 | 581,192 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $103,125,460 | 555,573 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $106,862,742 | 510,036 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $88,361,858 | 497,253 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $89,442,246 | 452,918 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,796,574 | 441,911 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $71,025,737 | 390,037 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $60,201,505 | 388,472 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $57,452,941 | 385,435 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,206,361 | 335,533 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,960,136 | 125,244 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,292,882 | 125,567 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,069,902 | 119,737 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,068,897 | 117,974 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $19,698,958 | 121,516 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,731,455 | 101,414 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $5,987,323 | 55,505 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,199,575 | 46,161 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,358,452 | 40,274 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $4,084,236 | 38,117 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $3,539,336 | 40,408 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,552,250 | 36,181 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,286,309 | 30,008 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||